Landos Biopharma Total Shareholders Equity 2011-2026 | LABP

Annual Total Shareholders Equity Landos Biopharma

2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
31.8 M	39.1 M	76.3 M	-54 M	-	-	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
76.3 M	-54 M	23.3 M

Quarterly Total Shareholders Equity Landos Biopharma

2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
37.7 M	43.3 M	47 M	39.1 M	44 M	51.5 M	62.1 M	76.3 M	93.9 M	106 M	101 M	-54 M	-54 M	-54 M	-54 M	-25.6 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
106 M	-54 M	28.8 M

Total Shareholders Equity of other stocks in the Biotechnology industry

Issuer	Total Shareholders Equity	Price	% 24h	Market Cap	Country
Anavex Life Sciences Corp. AVXL	94.9 M	$ 3.02	1.0 %	$ 258 M	USA
MorphoSys AG MOR	621 M	-	2.43 %	$ 254 M	Germany
BioNTech SE BNTX	1.37 B	$ 90.9	-0.31 %	$ 27.2 B	Germany
BioLineRx Ltd. BLRX	22 M	$ 2.34	5.72 %	$ 908 M	Israel
I-Mab IMAB	1.72 B	-	-	$ 866 M	China
Genfit SA GNFT	-16.2 M	-	2.54 %	$ 160 B	France
Biophytis SA BPTS	2.27 M	-	-13.47 %	$ 169 M	France
Midatech Pharma plc MTP	6.72 M	-	-18.52 %	$ 27.3 M	Britain
Codexis CDXS	50.5 M	$ 1.93	6.04 %	$ 168 M	USA
Cerus Corporation CERS	64.2 M	$ 1.9	1.88 %	$ 362 M	USA
Acorda Therapeutics ACOR	-158 M	-	-24.86 %	$ 820 K	USA
Cullinan Management CGEM	409 M	$ 15.2	5.34 %	$ 916 M	USA
Adverum Biotechnologies ADVM	70.7 M	-	-	$ 86.2 M	USA
Advaxis ADXS	-24.4 M	-	-9.65 %	$ 45.9 M	USA
Coherus BioSciences CHRS	61 M	$ 1.69	-2.31 %	$ 198 M	USA
Applied Molecular Transport AMTI	60.8 M	-	-	$ 10.1 M	USA
AgeX Therapeutics AGE	-37 K	-	-10.17 %	$ 12.2 K	USA
AIkido Pharma AIKI	69.4 M	-	1.93 %	$ 17.4 M	USA
Aeglea BioTherapeutics AGLE	715 M	-	-	$ 1.01 B	USA
Applied Genetic Technologies Corporation AGTC	29.5 M	-	-	$ 26.5 M	USA
Akero Therapeutics AKRO	750 M	-	-	$ 3.67 B	USA
Akouos AKUS	234 M	-	0.23 %	$ 488 M	USA
CollPlant Biotechnologies Ltd. CLGN	13.5 M	$ 0.46	-13.46 %	$ 5.27 M	Israel
Allena Pharmaceuticals ALNA	18.9 M	-	3.16 %	$ 1.9 M	USA
Alpine Immune Sciences ALPN	179 M	-	-	$ 2.17 B	USA
Aileron Therapeutics ALRN	16.9 M	-	10.36 %	$ 9.8 M	USA
Aquestive Therapeutics AQST	-33.7 M	$ 4.11	-0.48 %	$ 439 M	USA
CNS Pharmaceuticals CNSP	4.52 M	$ 2.27	0.39 %	$ 1.01 M	USA
Catalyst Pharmaceuticals CPRX	954 M	$ 24.91	0.89 %	$ 3.05 B	USA
Aravive ARAV	10.7 M	-	-13.39 %	$ 1.45 M	USA
Arcturus Therapeutics Holdings ARCT	214 M	$ 8.3	3.36 %	$ 227 M	Israel
Corbus Pharmaceuticals Holdings CRBP	148 M	$ 10.37	1.97 %	$ 138 M	USA
Cardiff Oncology CRDF	45.4 M	$ 1.6	0.95 %	$ 107 M	USA
Curis CRIS	5.46 M	$ 0.53	-3.64 %	$ 6.98 M	USA
Crinetics Pharmaceuticals CRNX	992 M	$ 38.09	2.31 %	$ 3.58 B	USA
CRISPR Therapeutics AG CRSP	1.92 B	$ 49.43	-0.17 %	$ 4.44 B	Schweiz
Aptose Biosciences APTO	-27.2 M	-	-45.71 %	$ 1.2 M	Canada
Aptinyx APTX	38.3 M	-	-39.0 %	$ 4.57 M	USA
CytomX Therapeutics CTMX	99 M	$ 4.41	-3.4 %	$ 608 M	USA
Citius Pharmaceuticals CTXR	70.1 M	$ 0.87	1.26 %	$ 5.85 M	USA
Cue Biopharma CUE	26.4 M	$ 0.17	-7.12 %	$ 16.1 M	USA
CureVac N.V. CVAC	688 M	-	-	$ 867 M	Germany
AstraZeneca PLC AZN	15.6 B	-	-	$ 96.9 B	Britain
Celldex Therapeutics CLDX	527 M	$ 31.43	1.18 %	$ 2.09 B	USA
Cyclerion Therapeutics CYCN	8.85 M	$ 4.34	-29.51 %	$ 10.9 M	USA
Avenue Therapeutics ATXI	1.83 M	-	-52.27 %	$ 4.45 M	USA